Overview
Japanese Encephalitis (JE) is a mosquito-borne viral disease caused by the Japanese Encephalitis Virus (JEV), a flavivirus closely related to dengue, yellow fever, and West Nile viruses. It is the leading cause of viral encephalitis in Asia and the Western Pacific region.
The virus is transmitted to humans through the bite of infected Culex species mosquitoes, which acquire the virus by feeding on amplifying hosts such as pigs and wading birds. Humans are considered dead-end hosts because they do not develop sufficient viremia to sustain transmission. Most human infections are asymptomatic, but less than 1% progress to severe, life-threatening encephalitis with high mortality and long-term neurological sequelae.
Pathophysiology of JEV Infection
After a mosquito bite, the virus initially replicates at the site of inoculation and in regional lymph nodes. This is followed by a transient viremia. In most individuals, the immune system clears the virus before it reaches the central nervous system, resulting in subclinical disease.
In cases where the virus invades the central nervous system, acute encephalitis develops. Inflammation and edema occur in the cerebral hemispheres, brain stem, cerebellum, and occasionally the spinal cord. Severe infections may show petechial hemorrhages. This neuroinflammatory process is responsible for the serious clinical manifestations of JE.
Importance of Serology in Diagnosis
Serological testing is the most important diagnostic tool for Japanese encephalitis. Because humans are dead-end hosts, the level of virus in the bloodstream remains very low, especially once neurological symptoms appear. As a result, molecular tests such as PCR often have limited sensitivity.
In contrast, the host immune system produces virus-specific antibodies in sufficient quantities. Detection of JEV-specific IgM and IgG antibodies in serum or cerebrospinal fluid, therefore, serves as the primary laboratory marker for diagnosis of JE infection.
Clinical Symptoms
The incubation period of Japanese encephalitis ranges from 5 to 15 days. Initial symptoms include fever, headache, and vomiting. Over the next few days, neurological features such as disorientation, weakness, seizures, and coma may develop.
Seizures are particularly common in children. Although more than 99% of infected individuals remain asymptomatic or develop only mild illness, those who develop neurologic disease face a significant risk. Mortality ranges from 20% to 25%. Among survivors, 30% to 50% continue to suffer from long-term neurological, cognitive, or psychiatric complications.
Indications for JEV Antibody Testing
Testing for Japanese encephalitis IgG and IgM antibodies is indicated in patients with acute encephalitis syndrome who have recently traveled to or reside in endemic areas. A detailed travel history is critical for the correct interpretation of results.
Even when other arthropod-borne viral infections are suspected, JEV antibody testing is essential if the clinical presentation is consistent with encephalitis and there is epidemiological risk of exposure.
Understanding IgM and IgG Antibodies
JEV IgM antibodies are typically detectable in serum or cerebrospinal fluid between 3 and 8 days after onset of illness. IgM is the most useful marker for early diagnosis and indicates recent infection. These antibodies usually persist for 30 to 90 days, though longer persistence has been documented.
JEV IgG antibodies are long-lasting and indicate past infection or prior vaccination. IgG testing is particularly useful when paired serum samples are analyzed. A four-fold or greater rise in IgG titer between acute and convalescent samples confirms recent infection.
Cross-reactivity is an important challenge because of antigenic similarities among flaviviruses, especially dengue. Interpretation must consider geographic location, vaccination history, and circulating viruses.
Sample Collection and Handling
For serological testing, 3.0 mL of blood is collected in a plain red-capped tube. Serum should be separated as early as possible and sent to the laboratory promptly. Grossly hemolyzed samples are rejected.
For central nervous system involvement, 3.0 mL of cerebrospinal fluid is collected by lumbar puncture in a sterile plain tube. Laboratory diagnosis of JE is commonly achieved by detecting virus-specific IgM antibodies in serum or CSF.
Assay Methods
Japanese encephalitis antibodies are detected using semi-quantitative enzyme-linked immunosorbent assay techniques. IgM is detected using MAC-ELISA (IgM capture ELISA), while IgG is detected using capture ELISA methods.
These assays allow reliable detection and differentiation of recent versus past infection.
Reference Range and Interpretation
For IgG antibodies, values of 1.9 IV or less are considered negative, 2.0–5.0 IV equivocal, and 5.1 IV or greater positive. A positive IgG result may indicate current or past infection.
For IgM antibodies, values of 3.9 IV or less are negative, 4.0–6.0 IV equivocal, and 6.1 IV or greater positive. A positive IgM result indicates current or recent infection, although low levels may persist for more than 12 months in some cases.
In early infection, IgG may be absent while IgM is detectable. Confirmation may require paired samples or more specific testing.
Role of PRNT
The Plaque Reduction Neutralization Test (PRNT) is considered the gold standard for confirming flavivirus infections. It measures neutralizing antibodies and helps distinguish JEV from other flaviviruses such as dengue.
A confirmed diagnosis requires a significantly higher neutralizing antibody titer against JEV compared to other flaviviruses, usually demonstrated by a four-fold difference.
Clinical Significance and Limitations
JEV IgG and IgM testing is essential for differentiating Japanese encephalitis from other causes of viral encephalitis. Accurate diagnosis supports appropriate supportive management, as no specific antiviral therapy exists.
Limitations include false-negative results in early samples, false-positive IgM after recent vaccination, and cross-reactivity with other flaviviruses. In such cases, confirmatory testing using PRNT is recommended.
